Medplus Health Services Ltd
₹ 670
-0.22%
22 Jul
- close price
About
Key Points
- Market Cap ₹ 8,014 Cr.
- Current Price ₹ 670
- High / Low ₹ 978 / 598
- Stock P/E 122
- Book Value ₹ 132
- Dividend Yield 0.00 %
- ROCE 6.83 %
- ROE 4.27 %
- Face Value ₹ 2.00
Pros
- Company's working capital requirements have reduced from 84.8 days to 67.6 days
Cons
- Stock is trading at 5.08 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company has a low return on equity of 5.04% over last 3 years.
- Promoters have pledged 54.2% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Upcoming result date: 2 August 2024
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
1,368 | 1,733 | 2,011 | 2,131 | 2,273 | 2,871 | 3,069 | 3,779 | 4,558 | 5,625 | |
1,336 | 1,696 | 1,940 | 2,073 | 2,153 | 2,737 | 2,852 | 3,507 | 4,292 | 5,271 | |
Operating Profit | 32 | 37 | 71 | 58 | 120 | 134 | 217 | 273 | 266 | 354 |
OPM % | 2% | 2% | 4% | 3% | 5% | 5% | 7% | 7% | 6% | 6% |
4 | 8 | 7 | 8 | 11 | 17 | 21 | 31 | 46 | 40 | |
Interest | 14 | 17 | 19 | 28 | 50 | 47 | 55 | 66 | 83 | 96 |
Depreciation | 9 | 10 | 11 | 12 | 59 | 75 | 88 | 119 | 182 | 224 |
Profit before tax | 14 | 19 | 48 | 26 | 23 | 29 | 95 | 118 | 47 | 73 |
Tax % | 46% | 52% | 40% | -65% | 48% | 94% | 34% | 20% | -6% | 11% |
7 | 9 | 29 | 42 | 12 | 2 | 63 | 95 | 50 | 66 | |
EPS in Rs | 419.34 | 508.71 | 1,620.57 | 2,080.06 | 585.46 | 107.02 | 1,393.11 | 8.03 | 4.17 | 5.48 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 22% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 40% |
3 Years: | 2% |
TTM: | 38% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -27% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 5% |
Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 |
Reserves | 141 | 137 | 148 | 303 | 291 | 528 | 730 | 1,394 | 1,467 | 1,554 |
170 | 223 | 204 | 162 | 429 | 477 | 590 | 815 | 900 | 1,010 | |
126 | 149 | 183 | 179 | 239 | 344 | 245 | 361 | 406 | 417 | |
Total Liabilities | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 |
67 | 77 | 81 | 83 | 377 | 419 | 517 | 799 | 1,138 | 1,247 | |
CWIP | 3 | 3 | 2 | 1 | 1 | 5 | 6 | 20 | 25 | 5 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
368 | 429 | 453 | 560 | 580 | 924 | 1,043 | 1,775 | 1,633 | 1,752 | |
Total Assets | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
-19 | -17 | 34 | 32 | 147 | -7 | 3 | 170 | 90 | 144 | |
-16 | -32 | -15 | -18 | -19 | -28 | -35 | -703 | 429 | -83 | |
67 | 35 | -29 | -1 | -83 | 90 | -6 | 440 | -170 | -198 | |
Net Cash Flow | 32 | -15 | -10 | 14 | 45 | 56 | -37 | -93 | 350 | -137 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Inventory Days | 84 | 82 | 76 | 76 | 78 | 101 | 113 | 112 | 117 | 111 |
Days Payable | 34 | 29 | 25 | 27 | 31 | 37 | 22 | 30 | 27 | 21 |
Cash Conversion Cycle | 51 | 53 | 51 | 51 | 48 | 65 | 91 | 82 | 91 | 92 |
Working Capital Days | 42 | 41 | 39 | 39 | 31 | 45 | 69 | 121 | 66 | 68 |
ROCE % | 11% | 19% | 13% | 12% | 9% | 13% | 10% | 5% | 7% |
Documents
Announcements
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 1d
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 2d
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 19 Jul
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 17 Jul
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 16 Jul
Annual reports
Concalls
-
May 2024Transcript PPT
-
Feb 2024TranscriptPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
India’s Leading Pharmacy company[1] MedPlus Health Services is the second-largest pharmacy retailer in India in terms of revenue and number of stores. The company has 4089 stores across the states of Telangana (679 stores), Andhra Pradesh (454 stores), Karnataka (893 stores), Tamil Nadu (845 stores), West Bengal (506 stores), Maharashtra (553 stores), and Odisha (149 stores), Chattisgarh (4 stores) Madhya Pradesh (4 stores) as of H1FY24.